Is GHC a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Graham Holdings Company (GHC) rests on Education (Kaplan) as the core engine: Education is the largest division, contributing roughly a third of consolidated revenue, anchored by Kaplan's higher education, professional and international units. Revenue (TTM) is ~$4.9B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Reported earnings are lumpy because they include unrealized gains and losses on the equity portfolio and periodic impairment charges, which can obscure underlying operating trends. Whether GHC is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Graham Holdings Company (NYSE: GHC) is a diversified holding company headquartered in Arlington, Virginia. Its largest division is education, run through Kaplan, which provides higher education services (including the Purdue Global relationship), professional test prep and supplemental and international education. Beyond Kaplan, Graham owns Graham Media Group (a group of local television stations), CSI Pharmacy in home-infusion healthcare, a manufacturing group of industrial businesses, automotive dealerships, and a collection of Other Businesses that includes brands like Slate, Foreign Policy, Framebridge, Clyde's Restaurant Group and several digital and marketing properties. It also holds a substantial portfolio of marketable securities and equity-method stakes. The investment picture is that of a conglomerate valued on the sum of its parts rather than one theme. Revenue is roughly $4.9 billion on a trailing basis, with education the biggest contributor and healthcare (CSI) among the faster-growing segments. The stock trades at a very high nominal price on a small share count (a few million shares), and the Graham family retains voting control through a dual-class structure. Reported earnings are volatile because they include mark-to-market swings on the equity portfolio and periodic impairment charges, so many investors look at operating income by segment and book value alongside headline EPS.
What's the case for buying GHC?
1. Education (Kaplan) as the core engine
Education is the largest division, contributing roughly a third of consolidated revenue, anchored by Kaplan's higher education, professional and international units. Growth has come from Purdue Global fees and international enrollment, offset at times by softness in U.S. pathways programs. The division's stability and margins are the single biggest driver of consolidated results.
2. Healthcare (CSI Pharmacy) expansion
CSI Pharmacy, the home-infusion healthcare business, has been one of the fastest-growing segments, with revenue up sharply as it expands infusion treatment offerings and patient service areas. Management has leaned into healthcare as a growth avenue, though rapid expansion can pressure margins. Continued scaling here is a key swing factor for the growth narrative.
3. Capital allocation and sum-of-the-parts value
Like a smaller Berkshire, Graham deploys cash from its operating units into acquisitions, its manufacturing roll-up, share repurchases and a large marketable-securities portfolio. Buybacks on a small share count can meaningfully move per-share metrics. The investment case rests heavily on how well management redeploys capital across these varied businesses.
4. Media, manufacturing and portfolio pruning
Television broadcasting through Graham Media Group is a strong operating-income contributor in election years but faces cyclical political-ad swings and secular local-ad decline. The manufacturing group adds industrial diversification, while portfolio moves (such as divesting the Kaplan Languages Group) signal ongoing pruning toward higher-return units.
What are the risks to GHC?
Reported earnings are lumpy because they include unrealized gains and losses on the equity portfolio and periodic impairment charges, which can obscure underlying operating trends. Several segments face structural headwinds: local television advertising is in secular decline and depends on cyclical political spending, while the for-profit and pathways education market carries regulatory and enrollment risk. The dual-class structure concentrates voting control with the Graham family, limiting outside shareholder influence. The conglomerate structure also means a persistent sum-of-the-parts discount and complexity that makes the business hard to value on a single metric. Rapid healthcare expansion and acquisitions add integration and margin risk.
How is GHC valued? (as of July 2026)
Snapshot for GHC as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$4.9B
- Q1 2026 revenue: ~$1.24B (up ~6% YoY)
- Q1 2026 operating income: ~$58M
- Market cap: ~$4.9B
- Education share of revenue: ~35%
- Shares outstanding: ~4.4M (small float, high nominal price)
Graham trades at a market value roughly in line with its trailing revenue, reflecting its conglomerate, sum-of-the-parts profile rather than a high-growth multiple. Headline EPS is distorted by mark-to-market movements on its investment portfolio and one-off impairment charges, so operating income by segment and book value are commonly used alongside it. The very small share count means per-share figures and buybacks carry outsized weight.
How do you decide if GHC is a buy?
Rather than asking whether GHC is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold GHC indirectly through an index or sector ETF before adding more.
For the full picture, see the GHC stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about GHC against your real portfolio and see your actual exposure before deciding.
The bottom line on GHC
The bottom line: Graham Holdings Company's story right now is Education (Kaplan) as the core engine, with revenue (ttm) at ~$4.9B. If you believe that narrative continues, the call is about sizing GHC sensibly and checking overlap with what you own; if you doubt it (the risk: reported earnings are lumpy because they include unrealized gains and losses on the equity portfolio and periodic impairment charges, which can obscure underlying operating trends.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around GHC with Walnut
Use Graham Holdings Company as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is GHC a good stock to buy right now?
+
The case for Graham Holdings Company right now is Education (Kaplan) as the core engine, with revenue (ttm) at ~$4.9B. If you believe that thesis holds, GHC is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is reported earnings are lumpy because they include unrealized gains and losses on the equity portfolio and periodic impairment charges, which can obscure underlying operating trends. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Graham Holdings Company do?
+
Graham Holdings Company (NYSE: GHC) is a diversified holding company headquartered in Arlington, Virginia.
What are the main risks of GHC?
+
Reported earnings are lumpy because they include unrealized gains and losses on the equity portfolio and periodic impairment charges, which can obscure underlying operating trends. Several segments face structural headwinds: local television advertising is in secular decline and depends on cyclical political spending, while the for-profit and pathways education market carries regulatory and enrollment risk. The dual-class structure concentrates voting control with the Graham family, limiting outside shareholder influence. The conglomerate structure also means a persistent sum-of-the-parts discount and complexity that makes the business hard to value on a single metric. Rapid healthcare expansion and acquisitions add integration and margin risk.
What does Graham Holdings Company do?
+
It is a diversified holding company that owns operating businesses across education (Kaplan), television broadcasting (Graham Media Group), home healthcare (CSI Pharmacy), manufacturing and automotive dealerships, plus media brands and a large investment portfolio.
Is GHC the same as the Washington Post Company?
+
GHC is the successor to The Washington Post Company. After the newspaper was sold to Jeff Bezos in 2013, the remaining company was renamed Graham Holdings and no longer owns the Post.
What is Graham Holdings' largest business?
+
Education, through its Kaplan subsidiary, is the largest division and made up roughly 35% of consolidated revenue in 2025, spanning higher education, professional, supplemental and international education services.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell GHC; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.